Cargando…

Toll-like receptor 2: therapeutic target for gastric carcinogenesis

Detalles Bibliográficos
Autores principales:	McCormack, William, Oshima, Masanobu, Tan, Patrick, Jenkins, Brendan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717785/ https://www.ncbi.nlm.nih.gov/pubmed/23175464

Ejemplares similares

Toll-like receptors and NOD-like receptors in rheumatic diseases
por: McCormack, William J, et al.
Publicado: (2009)

Toll-like Receptor 9 Promotes Initiation of Gastric Tumorigenesis by Augmenting Inflammation and Cellular Proliferation
por: Tang, Ke, et al.
Publicado: (2022)

Inflammation in gastric cancer: Interplay of the COX‐2/prostaglandin E(2) and Toll‐like receptor/MyD88 pathways
por: Echizen, Kanae, et al.
Publicado: (2016)

Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
por: Lepper, Philipp M., et al.
Publicado: (2010)

Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis
por: Kauppila, Joonas H., et al.
Publicado: (2013)

Toll-like receptors and their role in carcinogenesis and anti-tumor treatment
por: Wolska, Anna, et al.
Publicado: (2008)

Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis
por: Fels Elliott, Daffolyn Rachael, et al.
Publicado: (2017)

Toll‐like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2
por: Liu, You Dong, et al.
Publicado: (2019)

Face à la pénurie mondiale de personnels infirmiers, n’oublions pas « la personne »
por: McCormack, Brendan
Publicado: (2023)

Toll-Like Receptor Signaling in Liver Diseases
por: Szabo, Gyongyi, et al.
Publicado: (2010)

Role of Toll-Like Receptor 4 in Colorectal Carcinogenesis: A Meta-Analysis
por: Li, Xiao-Xia, et al.
Publicado: (2014)

Toll-like receptor 9 polymorphisms and Helicobacter pylori influence gene expression and risk of gastric carcinogenesis in the Brazilian population.
por: Susi, Manoela Dias, et al.
Publicado: (2019)

Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
por: Muccioli, Maria, et al.
Publicado: (2012)

Recent clinical trends in Toll‐like receptor targeting therapeutics
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2018)

Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
por: Farooq, Mariya, et al.
Publicado: (2021)

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease
por: Wu, Linyu, et al.
Publicado: (2022)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Cell recruitment in gastric carcinogenesis
por: Zhang, Songhua, et al.
Publicado: (2017)

Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
por: Abarca-Merlin, D. M., et al.
Publicado: (2019)

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems
por: Li, Haixia, et al.
Publicado: (2021)

Toll-like receptor 4 in COVID-19: friend or foe?
por: Mukherjee, Suprabhat
Publicado: (2022)

Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders
por: Ashayeri Ahmadabad, Rezan, et al.
Publicado: (2021)

HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
por: Ren, Wenxuan, et al.
Publicado: (2023)

Toll-Like Receptor Signaling Pathways—Therapeutic Opportunities
por: Zhu, Jiankun, et al.
Publicado: (2010)

Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome
por: Singh, Vijay K, et al.
Publicado: (2015)

Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
por: Jeong, Soung Won
Publicado: (2020)

Interplay of the Gastric Pathogen Helicobacter pylori with Toll-Like Receptors
por: Pachathundikandi, Suneesh Kumar, et al.
Publicado: (2015)

Targeting Toll-Like Receptors for Treatment of SLE
por: Horton, Christopher G., et al.
Publicado: (2010)

A new “sweet” ligand for Toll-like receptor 4
por: Deierborg, Tomas, et al.
Publicado: (2015)

Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
por: Kate Gadanec, Laura, et al.
Publicado: (2021)

Toll-like receptors and COVID-19: a two-faced story with an exciting ending
por: Onofrio, Livia, et al.
Publicado: (2020)

The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation
por: Kircheis, Ralf, et al.
Publicado: (2023)

Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2023)

Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014)

Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures
por: Nic An Ultaigh, Sinéad, et al.
Publicado: (2011)

Targeting Toll-like receptor 4 prevents cobalt-mediated inflammation
por: Lawrence, Helen, et al.
Publicado: (2016)

Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo
por: Uehara, Yoshihiko, et al.
Publicado: (2014)

Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis
por: Bauer, Alison K, et al.
Publicado: (2009)

Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation
por: Tam, Janine S. Y., et al.
Publicado: (2021)

Trapped in a vicious loop: Toll-like receptors sustain the spontaneous cytokine production by rheumatoid synovium
por: Abdollahi-Roodsaz, Shahla, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_drto8j2vv780qp43aj1bs6mvuu